UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 5, 2024
Accession Number:
0001193125-24-057844
Submission Type:
POS AM
CIK:
0001624422
Company Name:
PHAXIAM Therapeutics S.A.
File Number:
333-259690